The management of benign prostatic hyperplasia (BPH) has become a significant concern for many men as they age. This condition, characterized by an enlarged prostate gland, can lead to uncomfortable urinary symptoms such as frequent urination, difficulty starting urination, and a weak urine stream. As a result, various treatment options have emerged to alleviate these symptoms and improve the quality of life for those affected. Among these options, two medications, Tamsulosin and Alfuzosin, have gained prominence for their effectiveness and relatively favorable side effect profiles. Both Tamsulosin and Alfuzosin belong to a class of drugs known as alpha-1 blockers, which work by relaxing the muscles in the prostate and bladder…